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Abstract 
Genetic interactions have been widely used to define functional relationships between proteins 
and pathways. In this study, we demonstrated that yeast synthetic lethal genetic interactions can 
be explained by the genetic interactions between domains of those proteins. The domain genetic 
interactions rarely overlap with the domain physical interactions from iPfam database and 
provide a complementary view about domain relationships. Moreover, we found that domains in 
multidomain yeast proteins contribute to their genetic interactions differently. The domain 
genetic interactions help more precisely define the function related to the synthetic lethal genetic 
interactions, and then help understand how domains contribute to different functionalities of 
multidomain proteins. Using the probabilities of domain genetic interactions, we were able to 
predict novel yeast synthetic lethal genetic interactions.  Furthermore, we had also identified 
novel compensatory pathways from the predicted synthetic lethal genetic interactions. Our study 
significantly improved the understanding of yeast mulitdomain proteins, the synthetic lethal 
genetic interactions and the functional relationships between proteins and pathways. 
 
Introduction 
Defining the functional relationships between proteins is one of the important tasks in the post-
genomic era. A classical approach to understand gene functional relationships is producing 
combination mutant in two genes to observe genetic interactions [1].  Genetic interaction refers to 
the phenomenon in which the combined effect of mutations of two genes differs from individual 
effects of each mutation [2]. In the extreme cases, mutation of two nonessential genes could lead 
to a lethal phenotype. This kind of genetic interactions is referred as synthetic lethal genetic 
interactions (SLGIs). The genome-wide SLGIs have attracted much attention as they are capable 
of defining the genome-wide functional relationships between proteins, pathways and complexes 
[2-4]. The SLGIs also have potential for finding drug target or drug combinations [5].  
Representing the structures and functions of proteins, protein domains are usually 
regarded as building blocks of proteins and are conserved during evolution. The mutation of a 
gene causes the loss of function of its protein product, which may accredit to the loss of protein 
domains in the protein product. Then, the effect of the mutation of two genes may be caused by 
the loss of protein domain combinations in both protein products. We refer the phenomenon in 
which combined effect of mutations of two domains in two proteins differs from individual 
effects of mutation of each domain as domain genetic interactions. The domain genetic 
interactions may correlate to SLGIs. We may use the domain genetic interactions to explain and 
predict the SLGIs. Furthermore, in multidomain proteins, different domains may fulfill different 
functions independently or collaboratively. Although genetic interaction analysis provides a 
promising method to understand the functional relationship between proteins [6], we cannot tell 
the contributions of different domains to certain functionality of multidomain proteins based on 
their genetic interactions. Studying the domain genetic interactions may help elucidate the SLGIs 
between multidomain proteins at domain level.  
Genetic interactions are usually identified by mutant screens [7]. Recently, high 
throughput technologies, such as synthetic genetic arrays (SGA) [8] or synthetic lethal analysis by 
microarrays (SLAM) [9], have been developed for parallel and massive detection of genetic 
interactions. However, even with high throughput methods, experimental discovery of SLGIs is 
still overwhelming. Therefore, it is of interest to computationally predict SLGIs. Several 
computational approaches have been proposed for the prediction of SLGIs [10-15] and various 
features, such as protein interactions, gene expression, functional annotation, gene location, 
protein network characteristics, and genetic phenotype, had been utilized by these methods. 
Recently, Park et al. [15] also used protein domains as one of the features to predict interactions, 
including genetic interactions. 
In our previous study [16], we performed a cross validation study on predicting SLGIs 
using protein domains as features. Our support vector machine (SVM) classifiers were able to 
achieve high performance with AUC (The area under the ROC curve) as 0.9272.  These results 
suggested that using domain information may catch the genetic relationships between proteins. In 
this study, we first applied the Maximum Likelihood estimation (MLE) approach to estimate the 
probabilities of domain genetic interactions from yeast SLGIs. The EM algorithm developed by 
Dempster et al. [17] has been used to iteratively compute the maximum likelihood. Recently, the 
MLE method had been used to infer domain physical interactions from protein physical 
interactions [18, 19]. We identified significant domain genetic interactions, which rarely overlap 
with the domain physical interactions from iPfam database [20]. We also showed that domains in 
multidomain yeast proteins contribute to their genetic interactions differently. Then, we used the 
probabilistic model to predict yeast SLGIs using the probabilities of domain genetic interactions. 
We were able to predict novel yeast SLGIs using probabilities of domain genetic interactions, 
which demonstrate the ability of protein domains in predicting SLGIs. We were also able to apply 
our predicted yeast SLGIs to understand the compensatory pathways. A complete description of 
our results and methods is given in the sections below. 
 
Results 
Identification of Significant Domain Genetic Interactions Using Maximum Likelihood 
Estimation 
By assuming the independences among domain genetic interactions, we estimated the 
probabilities of domain genetic interactions using the Maximum Likelihood estimation (MLE) 
method. The probability of a domain pair indicates its propensity to genetically interact. The high 
probability of a domain pair imply that number of SLGIs including the domain interactions is 
high comparing to the number of protein pairs including the domain interaction that are not 
genetically interacted. Then, we calculated an evidence score E [19] for each domain genetic 
interaction to estimate its relative significance. The E scores are not the standard likelihood ratio 
test as they are calculated using only the positive data [19]. The E scores indicate the relative 
significances of the domain pairs in the SLGIs. The probability and the E score give different 
view about the significances of domain genetic interactions. The high probabilities do not always 
correlate to high E score. For example, there are a large number of protein pairs including a single 
domain pair. If very few of them are SLGIs, the probability of the domain pair will be low. 
However, if that domain pair is the only domain pair in those SLGIs, it will have high E score. On 
the other hand, in case there are a large number of protein pairs containing the same multiple 
domain pairs, if most of the protein pairs are SLGIs, the probabilities of those domain pairs will 
be high. However, the E scores of those domain pairs will be relatively low as removing any of 
those domain pairs will have limited effect on the probabilities of SLGIs. Therefore, we used both 
the probability and E score to select significant domain genetic interactions.  
We first applied the MLE approach to the 7475 genetic interactions with both proteins 
having protein domains. We were able to assign probabilities and E scores to 11,189 domain 
pairs. Those domain genetic interactions are available on our website, www.genenetworks.net, for 
searching and downloading. We first selected the significant domain genetic interactions with E 
scores greater than or equal to 2.0, which corresponds to an approximate seven fold drop of the 
probability of SLGIs if this domain genetic interactions is excluded. Then, we selected the domain 
genetic interactions with probability greater than 0.5 even though they have low E score values. 
Totally, we obtained 3848 domain genetic interactions of 1027 domains. Table II lists top ten 
domain genetic interactions with the highest E scores. The probabilities of those ten domain 
genetic interactions vary from 0.013 to 0.8. The prefoldin domain dominates in the top ten domain 
genetic interactions (7 of 10). Our results are consistent with the findings of Le Meur and 
Gentleman [21], in which they showed that the prefoldin complex is in 9 of their top 10 pairs 
synthetic multi-protein complexes genetic interactions.  
Domain Genetic Interactions Rarely Overlap Domain Physical Interactions 
To investigate the relationship between domain genetic interactions and the domain physical 
interactions, we compared the 3848 significant domain genetic interactions with the domain 
physical interactions from the iPfam database [20]. There are 4030 domain physical interactions 
of 1867 domains in iPfam database (2008 version). Among them, 1556 domain physical 
interactions of 1048 domains exist in yeast proteins we studied. There are 422 domains in both the 
genetic and physical interactions. We applied the Fisher’s exact test in R to examine if domains 
participating genetic interactions are independent from domains participating in physical 
interactions. We obtained a p-value of 0.00025, which indicated a significant difference between 
two sets of protein domains. Furthermore, there are only 70 domain pairs overlapped between the 
1556 domain physical interactions and 3848 domain genetic interactions. The Fisher’s exact test 
obtained a p-value of 0, which showed that the domain genetic interactions significantly differ 
from the domain physical interactions. Thus, the domain genetic interaction is a new type of 
relationship among domains and can provide a complementary view about the relationships 
between domains. 
The Properties of Domain Genetic Interaction Network   
To obtain an overview of the domain genetic interactions, we modeled the domain genetic 
interactions as a network, in which each node represents a domain and each link represents a 
genetic interaction between two domains. Then, we examined the properties of this domain 
genetic interaction network. The average connectivity of the network is 7.392. The domain 
PF00022 (Actin) has the highest connections of 186.  The average shortest path among all nodes 
is 3.31. Comparing the size of nodes, this number is very small. Furthermore, the average node 
clustering coefficient of the network is 0.159. These properties indicated that the domain genetic 
interaction network has the small world property [22]. The analysis of the connectivity 
distribution of this network showed a power-law distribution with an exponent degree of 1.45 
(Figure 1), which indicated that the domain genetic interaction network is a scale free network 
[23]. These results demonstrated that the domain genetic interaction network follows the common 
principles of biological networks [24].  
Domain Genetic Interactions in the SLGIs between Multidomain Proteins 
Most proteins are multidomain proteins, which are created as a result of different genetic events, 
such as insertions and duplications [25, 26]. Multidomain proteins may have different 
functionalities due to different domains. Our identification of domain genetic interactions helps 
understand the domains that contribute to functionality defined by the SLGIs, and then help 
elucidate the functional relationships between proteins at domain level from their genetic 
interactions.  
Figure 2 shows examples of domain genetic interactions in three SLGIs between yeast 
multidomain proteins. Figure 2A shows the domain genetic interactions between SGS1 and 
TOP1. The SGS1 has three domains and TOP1 has two domains. Only one of the three domains 
of SGS1, PF00570 (HRDC domain), has high probabilities to interact with two domains of 
TOP1: PF01028 (Eukaryotic DNA topoisomerase I catalytic core domain) and PF02919 
(Eukaryotic DNA topoisomerase I DNA binding domain). The other two domains: PF00270 
(DEAD/DEAH domain) and PF00271 (Helicase conserved C-terminal domain) of SGS1 have no 
genetic interaction with two domains of TOP1 (very low probabilities). Figure 2B shows the 
domain genetic interactions between TOP3 and TOP1. Both domains of TOP3: PF01131 (DNA 
topoisomerase domain) and PF01751 (Toprim domain) show high probabilities of genetic 
interaction with two domains of TOP1. Figure 2C shows the domain genetic interactions 
between RAD5 and RAD50. The RAD5 has four domains and RAD50 has two domains. The 
genetic interaction between RAD5 and RAD50 is mainly due to a single domain genetic 
interaction between PF08797 (HIRAN domain) of RAD5 and PF04423 (zinc hook domain) of 
RAD50. The PF00097 (Zinc finger domain), PF00176 (SNF2 family N-terminal domain) and 
PF00271 (Helicase conserved C-terminal domain) of RAD5 and PF02463 (RecF/RecN/SMC N 
terminal domain) of RAD50 have low contribution to the genetic interaction between RAD5 and 
RAD50. Those examples show different domain genetic interaction architectures in SLGIs 
between yeast multidomaon proteins. The domain genetic interactions may exist between all 
domains of two proteins (TOP3 and TOP1), or between part of domains of one protein and all 
domains of the other protein (SGS1 and TOP1), or between part of domains of one protein and 
part of domains of the other protein (RAD5 and RAD50).  The domain genetic interactions are 
able to help understand functional relationships between multidomain proteins at domain level. 
 We also investigated the domain genetic interactions of SLGIs between SGS1 and other 
proteins. We found that only the PF00570 (HRDC domain) of SGS1 has significant genetic 
interactions with other domains. The results implied that certain functionality of SGS1 may be 
only due to its HRDC domain, rather than its DEAD/DEAH domain and helicase conserved C-
terminal domain. Previous study showed that the HRDC domain of SGS1 is required for its 
cellular functions involving topoisomerases [27]. Thus, the domain genetic interaction analysis 
can help understand how domains contribute to the different functionalities of multidomain 
proteins. 
Prediction and Validation of Genome-wide SLGIs Using Protein Domains 
Having established that there is a strong correlation between domain genetic interactions and 
SLGIs, we explored to predict the probabilities of protein pairs to be SLGIs using probabilities of 
domain genetic interactions. We were able to assign 599752 protein pairs with probabilities 
greater than 0. Supplemental Table I lists the number of SLGIs predicted by MLE approach at 
different probability cutoffs. All predicted SLGIs are hosted on our website for searching and 
downloading. 
We then compared the correlation coefficients of gene expressions of predicted SLGIs to 
those of known SLGIs and those of all possible protein pairs. We used a yeast cell cycle gene 
expression data [28], which contains 77 data points. We calculated the T-score and P-value for 
the null hypothesis that there is no difference between the means of predicted SLGIs and the 
means of known SLGIs and the null hypothesis that there is no difference between the means of 
predicted SLGIs and the means of all pairs. The results are shown in Supplemental Table II. The 
correlation coefficients of gene expression of predicted SLGIs with threshold greater than 0.3 are 
similar to those of known SLGIs. The gene expression correlation coefficients of predicted 
SLGIs using different thresholds significantly differ from those of all pairs except for SLGIs 
with probabilities greater than 0.85, which have only small numbers of SLGIs. Those results 
indicated that the correlation coefficients of gene expressions of predicted SLGIs are similar to 
those of known SLGIs, rather than to those of random pairs. Recently, it was reported that the 
SLGIs are likely to have similar GO annotations [29]. We studied the distribution of similarities 
of Gene Ontology (GO) annotations between predicted SLGIs and also compared them to those 
of known SLGIs and all possible protein pairs. As shown in Supplemental Table III-V, the mean 
similarities of GO annotations of predicted SLGIs always significantly differ from those of all 
pairs. At certain probability thresholds, the mean similarities of GO annotations of predicted 
SLGIs show no significant differences from those of known SLGIs. Those thresholds are 0.35 
for biological process and cellular component and 0.25 for molecular function. As the probability 
thresholds increase, the mean similarities of GO annotations also increase, which will make them 
differ from those of known SLGIs. The studies of GO annotations similarities and expression 
correlation coefficients showed that the predicted SLGIs at probability threshold around 0.3 are 
similar to experimentally obtained SLGIs. 
Novel SLGIs predicted by MLE Approach 
The MLE approach was able to predict novel SLGIs. Table II lists 17 novel SLGIs (not included 
in our training data) with probability >0.9. We predicted the MYO4/DYN1 pair to be SLGI with 
the highest probability of 0.9895. The MYO4 is one of two type V myosin motors. The other one 
is MYO2, which is known to genetically interact with DYN1 [29]. Among 17 SLGIs, 12 SLGIs 
are between transcription initiation factor genes and genes from RNA polymerase complex. 
Previously, many SLGIs between transcription initiation factor genes and RNA polymerase 
genes have already been reported [30-32]. We expected our novel SLGIs to help further 
elucidate the transcription machine. We then investigated genes involved in cellular response to 
stresses caused by DNA damage. We downloaded a list of 116 DNA repair and recombination 
genes from Kyoto Encyclopedia of Genes and Genomes (KEGG) database [33]. Then, we 
extracted SLGIs in which at least one protein of SLGI pair are related to DNA repair. Figure 3 
shows the DNA repair related SLGIs with probability>0.7. Of a total of 133 SLGIs, 22 SLGIs 
are novel. Some of new predicted SLGIs are supported by previous studies. For example, the 
TOP3 and RAD1 double mutant has shown extreme synergistic growth defects in a previous 
study [34]. A recent study showed that the RTT109 and YKu70 double mutant exhibits 
synergistic defects under hydroxyurea treatment [35]. The PAP2 and POL2 were also shown to 
genetically interact at high temperatures [36]. 
Compensatory Pathways from Predicted SLGIs 
Protein pathways are a part of gene network in the cell that can accomplish certain functionality.  
The SLGIs have been proposed to have high probability of occurrence in compensatory 
pathways [37]. Thus, the SLGIs within the pathways are rare and the SLGIs between pathways 
are significantly abundant. Identification compensatory pathways from synthetic lethal genetic 
interactions can be a powerful way to understanding cellular functional relationships. We 
expected our new predictions will increase the ability of understanding compensatory pathways. 
We applied the algorithm of Ma [38] to identify compensatory pathways from 7583 predicted 
SLGIs with probability higher than 0.3. Among 7583 SLGIs, 4497 SLGIs are novel predictions. 
Although Ma et al. have shown that physical interactions are enriched in discovered pathways 
[38], there is no assumption that proteins in those pathways are physically interacting. Totally, 
we obtained 167 pairs of compensatory pathways, which include 638 proteins and 3535 SLGIs. 
Then, we examined the GO term co-occurrences in each pathway using the SGD GO Term 
Finder [39]. The GO Term Finder calculated the p-values that reflect the probability of observing 
the co-occurrence of proteins with a given GO term in a certain pathway by chance based on a 
binomial distribution. Among 167 compensatory pathway pairs, 153 pairs are found significantly 
enriched GO terms with p-value less than 0.05. All 167 pairs of compensatory pathways and 
their most significant GO terms are listed on our www.genenetworks.net website. 
Figure 4A and 4B lists two pairs of compensatory pathways related to DNA double 
strand break (DSB) repair. Among total 28 SLGIs between those two compensatory pathways, 
only 12 of them are known. The DSB is a kind of lethal DNA damage in which both strands of 
double helix are cleaved. The cell maintains multiple mechanisms to repair double strand breaks 
with the homologous recombination (HR) and non-homologous end joining (NHEJ) as two 
major mechanisms. Pathways involving those two mechanisms had shown to be compensatory to 
each other in Drosophila [40]. The pathways on the left of two compensatory pairs involve in 
NHEJ. The KU complex (YKU80 and YKU70) is the damage detector of NHEJ [41].  Mutation 
of nucleoporins NUP84 and NUP133 was reported to be hypersensitive to DNA damage  [42].  
Furthermore, the nucleoporins (NUP84 and NUP133) had been reported to colocalize and 
coimmunoprecipitate with Slx5/Slx8  [43], which regulate a DNA repair pathway that counteract 
Rad5-independent HR [44]. Our discovery suggested that the nucleoporins (NUP84 and 
NUP133) may regulate the NHEJ pathway through Ku complex for double strand breaks repair. 
The RAD24 is a DNA damage checkpoint protein [45]. Studies also had shown that the YKU80 
and RAD24 are in the same NHEJ pathways [45] to repair irradiation and 
methylmethanesulphonate (MMS) damages. The CSM3 is a DNA replication checkpoint protein. 
Genetic interaction between RAD24 and CSM3 may indicate the pathway on the right side of 
Figure 5 A can actually become two pathways: one is YKU80, RAD24, NUP84; the other is 
YKU80, CSM3 and NUP84.  
The pathways on the right of those two compensatory pairs of Figure 4 A and 4B involve 
in HR. On the right of Figure 4A, the pathway involves three proteins: RAD57, RAD51 and 
DMC1. The DMC1 and RAD51 are known to form a complex [46] and have roles in 
recombination [47]. RAD51 and RAD57 are in the same protein family and it has been shown 
that RAD57/RAD55 bind with RAD51 [48]. On the right of Figure 4B, the pathway involves 
four proteins: SGS1, RRP6, MRE11 and RAD52. The MRE11 and SGS1 are part of a two-step 
mechanism to initial HR [49].  The RAD52 plays a major role in the single strand annealing and 
strand exchange.  
Figure 4C also shows two compensatory DNA repair pathways. Among 18 SLGIs 
between two pathways, 11 are novel predictions. Many previous studies have supported our 
prediction of compensatory functionalities of those two pathways. Guillet and Boiteus [50] 
reported that the APN2 and MUS81/MMS4 have overlapping function to repair 3’-blocked 
single strand breaks (SSBs).  Vance and Wilson [51] showed that TDP1and RAD1 function as 
redundant pathways. SGS1/TOP3 had also been showed to overlap functionally with the 
MMS4/MUS81 [52]. Proteins in these compensatory pathways involve in many DNA-repair 
pathways, such as base excision repair (BER), nucleotide excision repair (NER) and HR. Studies 
already showed that BER, NER and HR pathways have overlapping specificities [53]. Our 
prediction of these compensatory pathways may help to understand the overlapping 
functionalities among BER, NER and HR pathways. 
Another interesting compensatory pathway pair is related to hydroperoxides response in 
the cell. As shown in Figure 4D, 11 of 15 SLGIs connecting two pathways are novel predictions. 
The three proteins (TSA1, TSA2 and PRX1) on the right are all thioredoxin peroxidase. They 
play a role in reduction of hydroperocxides in cytoplasm (TSA1 and TSA2) and mitochondrion 
(PRX1). Meanwhile, the five proteins (RAD52, RAD5, MDM31, MDM32, and MRE11) in the 
left pathway are related to DNA repair. RAD52, RAD5 and MRE11 are known related to double 
strand break repair [54-56]. The MDM31 and MDM32 relate the stability of mitochondrial DNA 
[57]. Those five proteins may relate to repair the damage created by the hydroperoxides. This 
compensatory pathway pair implies that removing hydroperoxides or repairing damage is 
alternative strategies for cells to survive from hydropeoxides. 
 
Discussion 
In this study, we demonstrated that the synthetic lethal genetic interactions between two proteins 
can be described by the genetic interactions between domains of those proteins. We applied a 
probabilistic model to successfully identify significant domain genetic interactions. The 
significant domain genetic interactions rarely overlap with the domain physical interactions from 
iPfam [20], which suggests that the domain genetic interactions and domain physical interactions 
are complementary to each other. The domain genetic interactions offer a better understanding of 
the relationship among domains, and then among proteins. Furthermore, with the identified 
domain genetic interactions, we showed that the contributions of domains in a multidomain 
protein to its genetic interactions are significantly different. The domain genetic interactions will 
help to decipher the domains that perform the function related to the genetic interaction. For 
example, analyzing the domain genetic interactions confirms that only the PF00570 (HRDC 
domain) of SGS1 involve in the cellular functions that are compensatory to topoisomerases.  
Our identification of domain genetic interactions and prediction of SLGIs is not 
complete. First, our training data is limited. It is believed that the available genetic interactions 
are just a small fraction of the whole genetic interactions [58]. Second, the training data largely 
come from several high-throughput genetic interaction screens, which emphasized certain 
biological processes, such as DNA repair. Thus, the probability of domain genetic interaction 
may be effected by the future available SLGIs. Moreover, we should keep in mind that our 
predicted SLGIs require further validation to exclude false positives. The MLE approach 
assumes the independence of domain genetic interactions. However, there may be dependence 
between domain genetic interactions. An apparent extension of this work is to consider the 
dependences among cooperative domains in multidomain proteins. Due to those limitations, the 
performance of predicting genome-wide SLGIs using protein domains may be not as good as 
other classifiers [11].  
In summary, our study significantly improved the understanding of different domains in 
mulitdomain proteins. The identification of domain genetic interactions helps the understanding 
of originality of functional relationship in SLGIs at domain level. Furthermore, our prediction of 
SLGIs expanded the ability to elucidate the functional relationships between proteins and 
pathways. 
 
Methods 
Source of Data 
We collected the protein domain data from Pfam (Protein families database) [59].  The Pfam 
database provides two types of protein family data.  Pfam-A domains are manually curated while 
Pfam-B domains are automatically generated. In our study, only Pfam-A domains were 
considered. The total number of selected Pfam-A domains for yeast is 2289. We downloaded the 
genetic interactions of yeast from the Saccharomyces Genome Database (SGD) [39] (July 2009 
version), which were compiled from different biological experiments [8, 60-66].  Then, we 
extracted synthetic lethal interaction data set from the file containing all the genetic interactions. 
After removing replicates, there were totally 10977 pairs of synthetic lethal interactions of 2640 
proteins.  We removed protein pairs from study if either protein in the pair does not contain any 
domain.  Eventually, we obtained 7475 synthetic lethal interactions among 2008 proteins. There 
were 1357 unique domains in those 7475 SLGIs. The information of SLGIs used in this study is 
summarized in Table III.  
Estimation of probabilities and significances of domain genetic interactions 
We treated the protein genetic interactions Pm,n and domain genetic interaction Di,j as random 
variables. The Pm,n=1 if two proteins i and j genetically interact and Pm,n =0 otherwise. The Di,j=1 
if two domain i and j genetically interact and Di,j=0 otherwise. We estimated the probabilities of 
potential domain interactions Pr(Di,j=1) by maximizing the likelihood of observed genetic 
interactions using the Expectation-Maximization (EM) algorithm [17-19]. The EM algorithm 
iteratively estimates the maximum likelihood of the ‘complete data’ that combine the observed 
data and unobserved data. Here, the protein genetic interactions and the domain information of 
proteins are our observed data and the domain genetic interactions are our unobserved data. By 
assuming the independences among domain genetic interactions, the likelihood of observed 
protein genetic interactions based on domain genetic interactions can be obtained as:  
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where Mi,j be the number of genetic interacting pairs between domain i and j in all protein genetic 
interactions; Ni,j be the number of non genetic interacting domain pairs between domain i and j in 
protein genetic interactions; and Ki,j be the number of non genetic interacting protein pairs 
including domain i in one protein and j in the other one. The value of Ki,j is counted from all 
possible protein pairs with domain i in one protein and j in the other one with excluding the 
known genetic interacting protein pairs. The Ki,j will keep unchanged during EM computation. 
The a and b are pseudo counts to avoid the Pr(Di,j =1) or Pr(Di,j =0) to be zero when instances of 
domains i and j are rare. We set both a and b to 1 in our calculation. Initially, the Mi,j was set to 
the number of genetic interactions between domain i and j in experimental genetic interactions; 
Ni,j is set to 0. And Pr(Di,j =1) was initialized as following: 
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In each Expectation step of EM algorithm, we first estimated the expected values of 
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]
))1Pr(1(1
)1Pr(
[][
, )(),( ,
,
,    

nm nDjmDi ji
ji
ji D
D
EME       (3) 
])
))1Pr(1(1
)1Pr(
[1(][
, )(),( ,
,
,    

nm nDjmDi ji
ji
ji D
D
EME      (4) 
Then, we calculate the Pr(Di,j =1) using the E[Mi,j] and E[Ni,j] as following (Maximization step): 
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The EM algorithm was iterated the above Expectation and Maximization steps till the change of 
likelihood L is less than a pre-defined small value.  
The evidence score  Ei,j [19] of domain pair i and j is defined as the ratio between the 
probability that a pair of proteins, m and n, genetically interact given that the pair of domains, i 
and j, genetically interact and the probability that a pair of proteins, m and n, genetically interact 
given that the pair of domains, i and j, do not genetically interact: 
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The )1Pr( ,, ji lkD  denotes the probability of genetic interacting between domains k and l given that 
the domains i and j do not genetically interact.  
Prediction of SLGIs using probabilities of domain genetic interactions 
We assumed that two proteins genetically interact (Pm,n =1) if and only if at least one domain 
pair from the two proteins genetically interact (Di,j =1). Then, we calculated the probability of 
two proteins genetically interacting Pr(Pm,n =1) as following: 
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A pair of proteins was predicted to be SLGI only if its probability is higher than a predefined 
threshold.  
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Figure Legends 
Figure 1. The log-log plot of degree distribution P(K) of domain genetic interaction 
network. The linear characteristics indicated by red line (y=x-1.45) imply that P(K) follows a 
power low. 
Figure 2. The domain genetic interactions in SLGIs between multidomain proteins. The 
thick lines indicate significant domain genetic interactions. The thin lines indicate the domain 
genetic interactions with low probability. The probabilities of domain genetic interactions are 
labeled besides the line.  
Figure 3.  The SLGIs (probabilities>0.7) related to DNA repair proteins. The cycles indicate 
DNA repair proteins and the triangle indicate non DNA repair proteins. Each genetic interaction 
involves at least one DNA repair protein. The wide links represent new genetic interactions. The 
figure was produced using Cytoscape [67]. 
Figure 4.  Compensatory pathways identified from predicted SLGIs. (A, B) two 
compensatory pathways related to DNA double strand breaks repairs. Pathways on the left of A 
and B belong to non-homologous end joining. Pathways on the right of A and B belong to 
homologous recombination. (C) A compensatory pathways related to DNA repairs. (D) A 
compensatory pathways related to hydroperoxides response in the cell. Dashed lines indicate 
known SLGIs and solid lines indicated novel predicted SLGIs. The figure was produced using 
Cytoscape [67]. 
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 Table I. Domain genetic interactions with top ten highest E scores. 
E 
score Prob. Domaina 
Domaina 
Pfam ID 
# of Yeast 
proteins 
with 
domaina 
Domainb 
Domainb 
Pfam ID 
# of Yeast 
proteins 
with 
domainb 
# 
of 
GI 
67.48 0.46 PF00225 Kinesin 6 PF01920 Prefoldin_2 4 11 
65.59 0.72 PF01302 CAP_GLY 4 PF01920 Prefoldin_2 4 12 
63.31 0.32 PF00022 Actin 9 PF01920 Prefoldin_2 4 11 
41.73 0.025 PF00071 Ras 24 PF00071 Ras 24 13 
39.53 0.036 PF00400 WD40 87 PF01920 Prefoldin_2 4 14 
38.41 0.12 PF00071 Ras 24 PF04893 Yip1 3 8 
36.53 0.027 PF00069 Pkinase 114 PF01920 Prefoldin_2 4 17 
35.15 0.35 PF00225 Kinesin 6 PF02996 Prefoldin 3 6 
33.16 0.80 PF01920 Prefoldin_2 4 PF03114 BAR 2 7 
31.20 0.013 PF00022 Actin 9 PF00069 Pkinase 114 17 
 
 Table II.  Predicted new synthetic lethal genetic interactions with probability greater than 0.9 
Protein 1 Protein 2 Probability 
Name Annotation Name Annotation 
MYO4  type V myosin motors   DYN1 Cytoplasmic heavy chain dynein  0.9895 
RPO21 RNA polymerase II largest 
subunit  
BRF1 TFIIIB B-related factor  0.9816 
DST1 General transcription elongation 
factor TFIIS  
RET1 Second-largest subunit of RNA 
polymerase III  
0.9797 
STO1 Large subunit of the nuclear 
mRNA cap-binding protein 
complex  
RPA190 RNA polymerase I subunit 0.9586 
STO1 Large subunit of the nuclear 
mRNA cap-binding protein 
complex  
RPO21 RNA polymerase II largest 
subunit  
0.9586 
DST1 General transcription elongation 
factor TFIIS  
RPA135 RNA polymerase I subunit 
A135 
0.9570 
BNR1 Formin,  nucleates the formation 
of linear actin filaments 
DYN1 Cytoplasmic heavy chain dynein  0.9441 
CEG1 Alpha (guanylyltransferase) 
subunit of the mRNA capping 
enzyme  
RPA190 RNA polymerase I subunit 0.9437 
CEG1 Alpha (guanylyltransferase) 
subunit of the mRNA capping 
enzyme 
RPO31 RNA polymerase III subunit  0.9437 
RPB5 RNA polymerase subunit  RPA190 RNA polymerase I subunit 0.9437 
RPB5 RNA polymerase subunit  RPO31 RNA polymerase III subunit 0.9437 
DST1 General transcription elongation 
factor TFIIS 
RPA190 RNA polymerase I subunit 0.9265 
DST1 General transcription elongation 
factor TFIIS 
RPO31 RNA polymerase III subunit  0.9265 
ARO1 Pentafunctional arom protein  SPT16 Subunit of the heterodimeric 
FACT complex  
0.9198 
RET1 Second-largest subunit of RNA 
polymerase III 
SUA7 Transcription factor TFIIB  0.9035 
BRF1 TFIIIB B-related factor  RET1 Second-largest subunit of RNA 
polymerase III 
0.9035 
BRF1 TFIIIB B-related factor RPB2 RNA polymerase II second 
largest subunit  
0.9035 
 
Table III.  Summary of SLGIs used in this study 
Number of known SLGIs with no replicates 10977 
Number of unique proteins in known SLGIs 2640 
Number of SLGIs between proteins with domains 7475 
Number of unique proteins in selected SLGIs 2008 
Number of unique domains in selected SLGIs 1357 
 
Additional files provided with this submission  
There are five supplemental Tables. More Supplement data are available on website 
www.genenetworks.net. 
 
